MoneyWorks4Me

Themis Medicare - Quaterly Results

07 Nov 2022 Evaluate
The sales is pegged at Rs. 910.03 millions for the September 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 1073.91 millions during the year-ago period.The Net Profit of the company registered a slight decline of -10.50% to Rs. 135.34  millions from Rs. 151.21 millions.A decline of 233.18 millions was observed in the OP in the quarter ended September 2022 from 236.75 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 910.03 1073.91 -15.26 1854.38 2198.95 -15.67 3946.14 2306.70 71.07
Other Income 19.74 2.13 826.76 26.59 5.62 373.13 65.41 36.22 80.59
PBIDT 233.18 236.75 -1.51 443.63 644.99 -31.22 1021.92 535.06 90.99
Interest 23.71 20.52 15.55 46.29 47.21 -1.95 87.74 127.12 -30.98
PBDT 209.47 216.23 -3.13 397.34 597.78 -33.53 934.18 407.94 129.00
Depreciation 25.64 23.75 7.96 50.24 47.25 6.33 94.80 85.46 10.93
PBT 183.83 192.48 -4.49 347.10 550.53 -36.95 839.38 322.48 160.29
TAX 48.49 41.27 17.49 95.42 131.98 -27.70 223.81 56.28 297.67
Deferred Tax 0.79 8.77 -90.99 1.42 34.48 -95.88 56.31 56.28 0.05
PAT 135.34 151.21 -10.50 251.68 418.55 -39.87 615.57 266.20 131.24
Equity 92.00 91.99 0.01 92.00 91.99 0.01 92.00 91.88 0.13
PBIDTM(%) 25.62 22.05 16.23 23.92 29.33 -18.44 25.90 23.20 11.64
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..